# Nicola Longo, M.D., Ph.D., Salt Lake City, UT – FDA Inspections

Source: https://www.keypedia.com/companies/nicola-longo-md-phd/6804c8d4-45f2-4d4f-aff5-53f75efcd948

> Inspection records and compliance data for Nicola Longo, M.D., Ph.D. in Salt Lake City, Utah. 2 FDA inspections on record, 1 Form 483, last inspected March 10, 2023.

---

## Details

- Name: Nicola Longo, M.D., Ph.D.
- FEI Number: 3010532531
- Address Line 1: 417 S Wakara Way Ste 3209
- City: Salt Lake City
- State: Utah
- Zip Code: 84108
- Country Name: United States
- Address: 417 S Wakara Way Ste 3209, Salt Lake City, Utah 84108, United States
- Country: United States

## Related Documents

- [483 - Nicola Longo, M.D., Ph.D. - 2023-03-10](https://www.keypedia.com/records/483/nicola-longo-md-phd/fb86af57-469d-4cd0-9dfc-9ffc3cb4685f) — source: FDA, date: March 10, 2023
- [FDA Inspection 1199605 - Nicola Longo, M.D., Ph.D. - 2023-03-10](https://www.keypedia.com/records/fda_inspections/nicola-longo-md-phd/1c332952-9ec7-49c4-86c4-b8e0065b562b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 10, 2023
- [EIR - Nicola Longo, M.D., Ph.D. - 2014-01-13](https://www.keypedia.com/records/eir/nicola-longo-md-phd/6256b0fa-6564-46a3-83cd-709137f446f7) — source: FDA, date: January 13, 2014
- [FDA Inspection 864458 - Nicola Longo, M.D., Ph.D. - 2014-01-13](https://www.keypedia.com/records/fda_inspections/nicola-longo-md-phd/6968926d-ebeb-45b5-acd6-584bfa80f6dd) — classification: No Action Indicated (NAI), source: FDA, date: January 13, 2014

## Related Companies

- [George Rodgers](https://www.keypedia.com/companies/george-rodgers/7eb05837-961d-436b-83e2-5a41ed149dee)
- [Christopher C. Canale, M.D.](https://www.keypedia.com/companies/christopher-c-canale-md/78012b01-f6b8-4bb2-9a0a-13de2c6d54cd)
- [Charles Parker, M.D.](https://www.keypedia.com/companies/charles-parker-md/c9ef4095-6a19-4ffe-bc5a-5c094b4ee286)
- [Isomeric Pharmacy Solutions, LLC](https://www.keypedia.com/companies/isomeric-pharmacy-solutions-llc/31bf3684-1983-4753-8f48-16c5b9563eca)
- [David Young, D.O.](https://www.keypedia.com/companies/david-young-do/500de342-4fcd-445f-91d3-61056100ef11)
- [HEATHER R. HARRISON, D.O.](https://www.keypedia.com/companies/heather-r-harrison-do/d60af014-efa4-4166-9405-ea6aa6cfe5fd)
- [Clarcon Biological Chemistry Laboratory Inc.](https://www.keypedia.com/companies/clarcon-biological-chemistry-laboratory-inc/394f8ef0-367c-46b1-bf52-ee980af079dd)
- [John F. Foley, MD](https://www.keypedia.com/companies/john-f-foley-md/1b2ef163-b5ad-4135-abce-589619730580)
- [Color Design Laboratory Inc.](https://www.keypedia.com/companies/color-design-laboratory-inc/8820f341-8ea0-43f0-84eb-4c284f9cebe6)
- [Sentynl Therapeutics, Inc.](https://www.keypedia.com/companies/sentynl-therapeutics-inc/5a7efa0e-6252-4b00-a536-f6dc78a34b00)

## Related Officers

- [recipient](https://www.keypedia.com/people/nicola-longo/29bd0b07-0829-419e-b913-94ce1be1fd75)
- [investigator](https://www.keypedia.com/people/stephen-t-hansen/7ae1f1df-7f68-4264-bd87-ea21c8d879bb)
- [Theressa B. Smith](https://www.keypedia.com/people/theressa-b-smith/80f0c339-7eac-4c73-b9f6-ecb368738fe6)
